Natera Inc (NTRA)

NASDAQ HEALTHCARE
$269.95 -4.22% RSI 62 Neutral Add Alert

Moving Averages

SMA 200
$213.15
Price above

Company Profile

Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$38.66B
P/E Ratio
None
EPS
$-1.62
Beta
1.505
Dividend Yield
0.00%
52-Week High
$288.04
52-Week Low
$131.81

Similar stocks in DIAGNOSTICS & RESEARCH

TMO
Thermo Fisher Scientific Inc
RSI 65.0
ILMN
Illumina Inc
RSI 65.0
MTD
Mettler-Toledo International Inc
RSI 63.0
CSTL
Castle Biosciences Inc
RSI 57.0
FONR
Fonar Corp
RSI 75.0
CRL
Charles River Laboratories International Inc
RSI 74.0
BDSX
Biodesix Inc
RSI 58.0
WGS
GeneDx Holdings Corp - Class A
RSI 55.0
DGX
Quest Diagnostics Inc
RSI 36.0
NEO
Neogenomics Inc
RSI 35.0

Data last updated: July 13, 2026 at 2:07 AM EDT

Track NTRA for free

Get e-mail RSI alerts when Natera Inc enters oversold or overbought territory. Free forever.

Add Alert